Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Caudal Dexmedetomidine for Sevoflurane Emergence Agitation in Pediatric Hernia Repair
NCT06734195Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Dec 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of propofol and dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Assiut University. Primary endpoint: Postoperative Emergence Agitation at 24 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
propofoldexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT06734195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06734195.